AI technologies conquer the drug developemt industry, giving faster results, with lower cost and more flexibility through simulation models.
Category: Forbes
Opioid Defendants Say Plaintiffs Stonewalling Them On Crucial Evidence
A looming showdown over evidence could determine the future path of more than 1,000 opioid lawsuits concentrated in federal court in Ohio.
The Forbes Healthcare Summit 2018: The Draft Agenda
We’re two weeks away from the big event. On November 28 we’ll host the Forbes Healthcare Summit, a 24-hour meeting (time off for sleep) of the top executives from the pharmaceutical, insurance and hospital sectors.
Meet Lia: At-Home Pregnancy Steps Into The 21st Century
Can entrepreneurship be taught? It’s a conversation I find myself having this talk quite often and my answer will unsurprisingly be yes. I give you, Anna Simpson and Bethany Edwards, co-founders of Lia Diagnostics and graduates of the University of Pen…
A Miracle Pill That Uses Metabolism to Slow Aging? This CEO Thinks So
Eating less and better is the sure-fire way to extend your lifespan. But what if there were a pill that could mimic the effects of calorie-restriction and slow down aging without fasting?
A Patient Complained About The Cost Of Her Medical Care (Here’s How Her Doctor Responded)
Patients pay a price for the inexplicably high cost of U.S. healthcare. Not just in the expense of copays and deductibles, but also through the harm of losing trust in our nation’s healthcare system.
Eaze Expands Delivery Of Nonpsychoactive Cannabis Across U.S.
In its latest effort of expansion, cannabis delivery platform, Eaze, made its next move in going nationwide with Eaze Wellness, a marketplace for industrial-hemp based CBD products.
A Spark Of Good News For Precision Oncology In Breast Cancer
In a trial of metastatic triple-negative breast cancer, AZD5363 significantly extended patients’ overall survival from 12.6 to 19.1 months, vs. placebo, when given with chemotherapy.
At 24, Two Entrepreneurs Took On Cancer. At 32, They’re Worth Hundreds Of Millions
Nat Turner and Zach Weinberg built Flatiron Health into a $2 billion company to pursue an impossible dream—combating cancer with big data. They’ve not only made fast progress, they’ve also gotten rich trying. A 30 Under 30 cover story.
This Is The Shocking Cost Of Type 1 Diabetes
It’s World Diabetes Day and I, as a Type 1 diabetic, want to delve a little deeper into the devastating game of debt VS death that so many of us have to play each day.
